FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
Overweight Individuals with Health Conditions : Adults with a BMI of 27 or higher who also have weight-related conditions such as type 2 diabetes, hypertension, or high cholesterol may be good candidates
Hector Perez, a board-certified bariatric surgeon, believes the interest in these probiotics could also be "an aftereffect of the success of GLP-1 drugs, which have now brought public focus on gut microbiome and weight loss." He notes that more people are beginning to connect that metabolism goes beyond calories and may be shaped by gut health
Benefits of Wegovy If you've been searching "who prescribes Wegovy near you" or "does Wegovy work for weight loss?" it's important to know the broader benefits beyond shedding pounds
When statins became inexpensive generics, clinical guidelines broadened eligibility, public health programmes expanded access, and reimbursement policies adapted to support equitable uptake
